Playback speed
10 seconds
ESMO 2024 Insights: Final OS With Niraparib as 1L Maintenance in Advanced Ovarian Cancer - PRIMA Trial
By
2024 ESMO Annual Meeting Insights Hub
FEATURING
Bradley J. Monk
By
2024 ESMO Annual Meeting Insights Hub
FEATURING
Bradley J. Monk
154 views
September 19, 2024
Login to view comments.
Click here to Login